{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:52:59Z","timestamp":1740127979027,"version":"3.37.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":2231,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA P01 49639"],"award-info":[{"award-number":["CA P01 49639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1074\/jbc.m114.554501","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T07:59:59Z","timestamp":1402646399000},"page":"21463-21472","source":"Crossref","is-referenced-by-count":9,"title":["c-Abl Activates Janus Kinase 2 in Normal Hematopoietic Cells"],"prefix":"10.1016","volume":"289","author":[{"given":"Wenjing","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip N.","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph B.","family":"Arlinghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.554501_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/CBB:41:2:207","article-title":"Jak2 tyrosine kinase: a true jak of all trades?","volume":"41","author":"Sandberg","year":"2004","journal-title":"Cell Biochem. Biophys"},{"key":"10.1074\/jbc.M114.554501_bib2","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/sj.onc.1203594","article-title":"IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled","volume":"19","author":"Reddy","year":"2000","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.M114.554501_bib4","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1043-2760(01)00423-4","article-title":"Signaling pathways activated by the growth hormone receptor","volume":"12","author":"Herrington","year":"2001","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.554501_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.554501_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.554501_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/gene.20063","article-title":"Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice","volume":"40","author":"Krempler","year":"2004","journal-title":"Genesis"},{"key":"10.1074\/jbc.M114.554501_bib9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1042\/BST20130005","article-title":"New insights into the structure and function of the pseudokinase domain in JAK2","volume":"41","author":"Silvennoinen","year":"2013","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.M114.554501_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.M114.554501_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","article-title":"The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation","volume":"134","author":"Hansen","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.554501_bib12","doi-asserted-by":"crossref","first-page":"e5188","DOI":"10.1371\/journal.pone.0005188","article-title":"A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex","volume":"4","author":"Dey","year":"2009","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M114.554501_bib13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.554501_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/protein\/14.1.27","article-title":"Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation","volume":"14","author":"Lindauer","year":"2001","journal-title":"Protein Eng"},{"key":"10.1074\/jbc.M114.554501_bib15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1091\/mbc.e02-06-0342","article-title":"Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain","volume":"14","author":"Saharinen","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M114.554501_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.554501_bib17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1074\/jbc.M114.554501_bib18","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.554501_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M114.554501_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrclinonc.2012.174","article-title":"Haematological cancer: Hit the lymphoma, JAK","volume":"9","author":"Kirk","year":"2012","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1074\/jbc.M114.554501_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M114.554501_bib22","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.554501_bib23","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2006-04-014712","article-title":"JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model","volume":"108","author":"Mercher","year":"2006","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.554501_bib24","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood-2006-09-045963","article-title":"Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia","volume":"109","author":"Malinge","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.554501_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.554501_bib26","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","article-title":"Myeloproliferative disorders","volume":"112","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.554501_bib27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2009.7","article-title":"Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients","volume":"28","author":"Samanta","year":"2009","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib28","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","article-title":"Janus kinase 2: a critical target in chronic myelogenous leukemia","volume":"66","author":"Samanta","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.554501_bib29","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-Myc induction by Bcr-Abl","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib30","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","article-title":"Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation","volume":"20","author":"Xie","year":"2001","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/leu.2010.287","article-title":"Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia","volume":"25","author":"Samanta","year":"2011","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M114.554501_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1\u03b1 from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M114.554501_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0962-8924(99)01549-4","article-title":"Cycling, stressed-out and nervous: cellular functions of c-Abl","volume":"9","author":"Van Etten","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.M114.554501_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0959-4388(99)00058-6","article-title":"From Abl to actin: Abl tyrosine kinase and associated proteins in growth cone motility","volume":"10","author":"Lanier","year":"2000","journal-title":"Curr. Opin. Neurobiol"},{"key":"10.1074\/jbc.M114.554501_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-230X(02)85003-5","article-title":"The Abl family kinases: mechanisms of regulation and signaling","volume":"85","author":"Pendergast","year":"2002","journal-title":"Adv. Cancer Res"},{"key":"10.1074\/jbc.M114.554501_bib36","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1074\/jbc.275.17.12725","article-title":"Interaction of the N-methyl-d-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase","volume":"275","author":"Glover","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.554501_bib37","doi-asserted-by":"crossref","first-page":"15174","DOI":"10.1073\/pnas.93.26.15174","article-title":"Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport","volume":"93","author":"Lewis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.554501_bib38","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1101\/gad.13.18.2400","article-title":"c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF","volume":"13","author":"Plattner","year":"1999","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M114.554501_bib39","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.4049\/jimmunol.165.12.6872","article-title":"The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19","volume":"165","author":"Zipfel","year":"2000","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M114.554501_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M114.554501_bib41","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M114.554501_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/onc.2013.84","article-title":"The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer","volume":"33","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib43","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/bcj.2013.41","article-title":"Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase","volume":"3","author":"Chakraborty","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1074\/jbc.M114.554501_bib44","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1073\/pnas.0501976102","article-title":"Capturing protein interactions in the secretory pathway of living cells","volume":"102","author":"Nyfeler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.554501_bib45","first-page":"298","article-title":"Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr","volume":"63","author":"Ling","year":"2003","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.554501_bib46","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1038\/sj.onc.1210979","article-title":"BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor","volume":"27","author":"Tao","year":"2008","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.554501_bib47","first-page":"4335","article-title":"JAK2 associates with the \u03b2 c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region","volume":"14","author":"Quelle","year":"1994","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M114.554501_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.554501_bib49","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1073\/pnas.90.18.8429","article-title":"Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction","volume":"90","author":"Silvennoinen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.554501_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(93)90415-M","article-title":"Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase","volume":"74","author":"Argetsinger","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.554501_bib51","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1073\/pnas.91.12.5232","article-title":"Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants","volume":"91","author":"Campbell","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.554501_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcb.20513","article-title":"Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba\/F3 pro-B cells","volume":"96","author":"Huang","year":"2005","journal-title":"J. Cell Biochem"},{"first-page":"1","year":"2006","author":"Moresco","key":"10.1074\/jbc.M114.554501_bib53"},{"key":"10.1074\/jbc.M114.554501_bib54","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1128\/MCB.24.6.2573-2583.2004","article-title":"Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor","volume":"24","author":"Plattner","year":"2004","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M114.554501_bib55","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1074\/jbc.M707125200","article-title":"Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F","volume":"283","author":"Lu","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.554501_bib56","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1074\/jbc.M109.071191","article-title":"Activation of JAK2-V617F by components of heterodimeric cytokine receptors","volume":"285","author":"Pradhan","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.554501_bib57","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1038\/sj.onc.1210500","article-title":"Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1","volume":"26","author":"Lin","year":"2007","journal-title":"Oncogene"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820475301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820475301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.554501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T16:27:57Z","timestamp":1641313677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820475301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":57,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0021925820475301"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.554501","relation":{},"ISSN":["0021-9258"],"issn-type":[{"type":"print","value":"0021-9258"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}